JME 4110: Evacuation Assist -- Go-Cart Ski Dragger

Most recently, we have watched news coverage of Ukrainians evacuating their homes with nothing more than a rolling suitcase! Is there an optimal subset of belongings to take and is there any device that could be designed to facilitate pedestrian evacuation

Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review

BackgroundVarying degrees of cortical amyloid deposition are reported in the setting of Parkinsonism with cognitive impairment. We performed a systematic review to estimate the prevalence of Alzheimer disease (AD) range cortical amyloid deposition among patients with Parkinson's disease with dementia (PDD), Parkinson's disease with mild cognitive impairment (PD‐MCI) and dementia with Lewy bodies (DLB). We included amyloid positron emission tomography (PET) imaging studies using Pittsburgh Compound B (PiB).MethodsWe searched the databases Ovid MEDLINE, PubMed, Embase, Scopus, and Web of Science for articles pertaining to amyloid imaging in Parkinsonism and impaired cognition. We identified 11 articles using PiB imaging to quantify cortical amyloid. We used the metan module in Stata, version 11.0, to calculate point prevalence estimates of patients with “PiB‐positive” studies, that is, patients showing AD range cortical Aβ‐amyloid deposition. Heterogeneity was assessed. A scatterplot was used to assess publication bias.ResultsOverall pooled prevalence of “PiB‐positive” studies across all three entities along the spectrum of Parkinson's disease and impaired cognition (specifically PDD, PD‐MCI, and DLB) was 0.41 (95% confidence interval [CI], 0.24‐0.57). Prevalence of “PiB‐positive” studies was 0.68 (95% CI, 0.55‐0.82) in the DLB group, 0.34 (95% CI, 0.13‐0.56) in the PDD group, and 0.05 (95% CI, −0.07‐0.17) in the PD‐MCI group.ConclusionsSubstantial variability occurs in the prevalence of “PiB‐positive” studies in subjects with Parkinsonism and cognitive impairment. Higher prevalence of PiB‐positive studies was encountered among subjects with DLB as opposed to subjects with PDD. The PD‐MCI subjects showed overall lower prevalence of PiB‐positive studies than reported findings in non–PD‐related MCI. © 2015 International Parkinson and Movement Disorder SocietyPeer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/111915/1/mds26191.pd

Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease

This is the peer reviewed version of the following article: Xie, L, Wisse, LEM, Pluta, J, et al. Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease. Hum Brain Mapp. 2019; 40: 3431 3451, which has been published in final form at https://doi.org/10.1002/hbm.24607. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.[EN] Medial temporal lobe (MTL) substructures are the earliest regions affected by neurofibrillary tangle pathology-and thus are promising biomarkers for Alzheimer's disease (AD). However, automatic segmentation of the MTL using only T1-weighted (T1w) magnetic resonance imaging (MRI) is challenging due to the large anatomical variability of the MTL cortex and the confound of the dura mater, which is commonly segmented as gray matter by state-of-the-art algorithms because they have similar intensity in T1w MRI. To address these challenges, we developed a novel atlas set, consisting of 15 cognitively normal older adults and 14 patients with mild cognitive impairment with a label explicitly assigned to the dura, that can be used by the multiatlas automated pipeline (Automatic Segmentation of Hippocampal Subfields [ASHS-T1]) for the segmentation of MTL subregions, including anterior/posterior hippocampus, entorhinal cortex (ERC), Brodmann areas (BA) 35 and 36, and parahippocampal cortex on T1w MRI. Cross-validation experiments indicated good segmentation accuracy of ASHS-T1 and that the dura can be reliably separated from the cortex (6.5% mislabeled as gray matter). Conversely, FreeSurfer segmented majority of the dura mater (62.4%) as gray matter and the degree of dura mislabeling decreased with increasing disease severity. To evaluate its clinical utility, we applied the pipeline to T1w images of 663 ADNI subjects and significant volume/thickness loss is observed in BA35, ERC, and posterior hippocampus in early prodromal AD and all subregions at later stages. As such, the publicly available new atlas and ASHS-T1 could have important utility in the early diagnosis and monitoring of AD and enhancing brain-behavior studies of these regions.Northern California Institute for Research and Education; Foundation for the National Institutes of Health; Canadian Institutes of Health Research; Transition Therapeutics; Takeda Pharmaceutical Company; Servier; Piramal Imaging; Pfizer Inc.; Novartis Pharmaceuticals Corporation; Neurotrack Technologies; NeuroRx Research; Meso Scale Diagnostics, LLC.; Lundbeck and Merck & Co., Inc.; Lumosity; Johnson & Johnson Pharmaceutical Research & Development LLC.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; IXICO Ltd.; GE Healthcare; Fujirebio; Genentech, Inc.; F. Hoffmann-La Roche Ltd.; EuroImmun; Eli Lilly and Company; Elan Pharmaceuticals, Inc.; Cogstate and Eisai Inc.; CereSpir, Inc.; Bristol-Myers Squibb Company; Biogen; BioClinica, Inc.; Araclon Biotech; Alzheimer's Drug Discovery Foundation; Alzheimer's Association; AbbVie; National Institute of Biomedical Imaging and Bioengineering; National Institute on Aging; Department of Defense ADNI, Grant/Award Number: W81XWH-12-2-0012; Alzheimer's Disease Neuroimaging Initiative, Grant/Award Number: U01 AG024904; Spain Ministry of Economy, Industry and Competitiveness, Grant/Award Number: DPI2017-87743-R; Foundation Philippe Chatrier; BrightFocus Foundation; National Institutes of Health, Grant/Award Numbers: R01-AG055005, R01-EB017255, P30-AG010124, R01-AG040271, R01-AG056014Xie, L.; Wisse, LEM.; Pluta, J.; De Flores, R.; Piskin, V.; Manjón Herrera, JV.; Wang, H.... (2019). Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease. Human Brain Mapping. 40(12):3431-3451. https://doi.org/10.1002/hbm.24607S343134514012Apostolova, L. G., Green, A. E., Babakchanian, S., Hwang, K. S., Chou, Y.-Y., Toga, A. W., & Thompson, P. M. (2012). Hippocampal Atrophy and Ventricular Enlargement in Normal Aging, Mild Cognitive Impairment (MCI), and Alzheimer Disease. Alzheimer Disease & Associated Disorders, 26(1), 17-27. doi:10.1097/wad.0b013e3182163b62Augustinack, J. C., Huber, K. E., Stevens, A. A., Roy, M., Frosch, M. P., van der Kouwe, A. J. W., … Fischl, B. (2013). Predicting the location of human perirhinal cortex, Brodmann’s area 35, from MRI. NeuroImage, 64, 32-42. doi:10.1016/j.neuroimage.2012.08.071AVANTS, B., EPSTEIN, C., GROSSMAN, M., & GEE, J. (2008). Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain. Medical Image Analysis, 12(1), 26-41. doi:10.1016/j.media.2007.06.004Bender, A. R., Keresztes, A., Bodammer, N. C., Shing, Y. L., Werkle‐Bergner, M., Daugherty, A. M., … Raz, N. (2017). Optimization and validation of automated hippocampal subfield segmentation across the lifespan. Human Brain Mapping, 39(2), 916-931. doi:10.1002/hbm.23891Berron, D., Vieweg, P., Hochkeppler, A., Pluta, J. B., Ding, S.-L., Maass, A., … Wisse, L. E. M. (2017). A protocol for manual segmentation of medial temporal lobe subregions in 7 Tesla MRI. NeuroImage: Clinical, 15, 466-482. doi:10.1016/j.nicl.2017.05.022BOBINSKI, M., WEGIEL, J., TARNAWSKI, M., BOBINSKI, M., REISBERG, B., DE LEON, M. J., … WISNIEWSKI, H. M. (1997). Relationships between Regional Neuronal Loss and Neurofibrillary Changes in the Hippocampal Formation and Duration and Severity of Alzheimer Disease. Journal of Neuropathology and Experimental Neurology, 56(4), 414-420. doi:10.1097/00005072-199704000-00010Boccardi, M., Bocchetta, M., Apostolova, L. G., Barnes, J., Bartzokis, G., Corbetta, G., … Frisoni, G. B. (2015). Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance. Alzheimer’s & Dementia, 11(2), 126-138. doi:10.1016/j.jalz.2014.02.009Boccardi, M., Bocchetta, M., Morency, F. C., Collins, D. L., Nishikawa, M., Ganzola, R., … Frisoni, G. B. (2015). Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol. Alzheimer’s & Dementia, 11(2), 175-183. doi:10.1016/j.jalz.2014.12.002Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82(4), 239-259. doi:10.1007/bf00308809Braak, H., & Braak, E. (1995). Staging of alzheimer’s disease-related neurofibrillary changes. Neurobiology of Aging, 16(3), 271-278. doi:10.1016/0197-4580(95)00021-6Chan, D., Fox, N. C., Scahill, R. I., Crum, W. R., Whitwell, J. L., Leschziner, G., … Rossor, M. N. (2001). Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Annals of Neurology, 49(4), 433-442. doi:10.1002/ana.92Chételat, G., Fouquet, M., Kalpouzos, G., Denghien, I., De la Sayette, V., Viader, F., … Desgranges, B. (2008). Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry. Neuropsychologia, 46(6), 1721-1731. doi:10.1016/j.neuropsychologia.2007.11.037Collins, D. L., & Pruessner, J. C. (2010). Towards accurate, automatic segmentation of the hippocampus and amygdala from MRI by augmenting ANIMAL with a template library and label fusion. NeuroImage, 52(4), 1355-1366. doi:10.1016/j.neuroimage.2010.04.193Coupé, P., Manjón, J. V., Fonov, V., Pruessner, J., Robles, M., & Collins, D. L. (2011). Patch-based segmentation using expert priors: Application to hippocampus and ventricle segmentation. NeuroImage, 54(2), 940-954. doi:10.1016/j.neuroimage.2010.09.018Das, S. R., Mancuso, L., Olson, I. R., Arnold, S. E., & Wolk, D. A. (2015). Short-Term Memory Depends on Dissociable Medial Temporal Lobe Regions in Amnestic Mild Cognitive Impairment. Cerebral Cortex, 26(5), 2006-2017. doi:10.1093/cercor/bhv022Das, S. R., Pluta, J., Mancuso, L., Kliot, D., Yushkevich, P. A., & Wolk, D. A. (2015). Anterior and posterior MTL networks in aging and MCI. Neurobiology of Aging, 36, S141-S150.e1. doi:10.1016/j.neurobiolaging.2014.03.041Davies, R. R., Halliday, G. M., Xuereb, J. H., Kril, J. J., & Hodges, J. R. (2009). The neural basis of semantic memory: Evidence from semantic dementia. Neurobiology of Aging, 30(12), 2043-2052. doi:10.1016/j.neurobiolaging.2008.02.005De Flores, R., La Joie, R., & Chételat, G. (2015). Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease. Neuroscience, 309, 29-50. doi:10.1016/j.neuroscience.2015.08.033De Flores, R., La Joie, R., Landeau, B., Perrotin, A., Mézenge, F., de La Sayette, V., … Chételat, G. (2014). Effects of age and Alzheimer’s disease on hippocampal subfields. Human Brain Mapping, 36(2), 463-474. doi:10.1002/hbm.22640De Vita, E., Thomas, D. L., Roberts, S., Parkes, H. G., Turner, R., Kinchesh, P., … Ordidge, R. J. (2003). High resolution MRI of the brain at 4.7 Tesla using fast spin echo imaging. The British Journal of Radiology, 76(909), 631-637. doi:10.1259/bjr/69317841Delli Pizzi, S., Franciotti, R., Bubbico, G., Thomas, A., Onofrj, M., & Bonanni, L. (2016). Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer’s disease. Neurobiology of Aging, 40, 103-109. doi:10.1016/j.neurobiolaging.2016.01.010Dice, L. R. (1945). Measures of the Amount of Ecologic Association Between Species. Ecology, 26(3), 297-302. doi:10.2307/1932409Dickerson, B. C., Goncharova, I., Sullivan, M. P., Forchetti, C., Wilson, R. S., Bennett, D. A., … deToledo-Morrell, L. (2001). MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease ☆ ☆This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. Neurobiology of Aging, 22(5), 747-754. doi:10.1016/s0197-4580(01)00271-8Ding, S.-L., & Van Hoesen, G. W. (2010). Borders, extent, and topography of human perirhinal cortex as revealed using multiple modern neuroanatomical and pathological markers. Human Brain Mapping, 31(9), 1359-1379. doi:10.1002/hbm.20940Ding, S.-L., Van Hoesen, G. W., Cassell, M. D., & Poremba, A. (2009). Parcellation of human temporal polar cortex: A combined analysis of multiple cytoarchitectonic, chemoarchitectonic, and pathological markers. The Journal of Comparative Neurology, 514(6), 595-623. doi:10.1002/cne.22053Ekstrom, A. D., Bazih, A. J., Suthana, N. A., Al-Hakim, R., Ogura, K., Zeineh, M., … Bookheimer, S. Y. (2009). Advances in high-resolution imaging and computational unfolding of the human hippocampus. NeuroImage, 47(1), 42-49. doi:10.1016/j.neuroimage.2009.03.017Fischl, B. (2012). FreeSurfer. NeuroImage, 62(2), 774-781. doi:10.1016/j.neuroimage.2012.01.021Fischl, B., Stevens, A. A., Rajendran, N., Yeo, B. T. T., Greve, D. N., Van Leemput, K., … Augustinack, J. C. (2009). Predicting the location of entorhinal cortex from MRI. NeuroImage, 47(1), 8-17. doi:10.1016/j.neuroimage.2009.04.033Frisoni, G. B., Jack, C. R., Bocchetta, M., Bauer, C., Frederiksen, K. S., Liu, Y., … Cavedo, E. (2015). The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity. Alzheimer’s & Dementia, 11(2), 111-125. doi:10.1016/j.jalz.2014.05.1756Fukutani, Y., Kobayashi, K., Nakamura, I., Watanabe, K., Isaki, K., & Cairns, N. J. (1995). Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer’s disease. Neuroscience Letters, 200(1), 57-60. doi:10.1016/0304-3940(95)12083-gGlasser, M. F., Sotiropoulos, S. N., Wilson, J. A., Coalson, T. S., Fischl, B., Andersson, J. L., … Jenkinson, M. (2013). The minimal preprocessing pipelines for the Human Connectome Project. NeuroImage, 80, 105-124. doi:10.1016/j.neuroimage.2013.04.127Greene, S. J., & Killiany, R. J. (2011). Hippocampal Subregions are Differentially Affected in the Progression to Alzheimer’s Disease. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, 295(1), 132-140. doi:10.1002/ar.21493Hu, S., Coupé, P., Pruessner, J. C., & Collins, D. L. (2012). Nonlocal regularization for active appearance model: Application to medial temporal lobe segmentation. Human Brain Mapping, 35(2), 377-395. doi:10.1002/hbm.22183Iglesias, J. E., Augustinack, J. C., Nguyen, K., Player, C. M., Player, A., Wright, M., … Van Leemput, K. (2015). A computational atlas of the hippocampal formation using ex vivo , ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI. NeuroImage, 115, 117-137. doi:10.1016/j.neuroimage.2015.04.042Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., … Dubois, B. (2016). A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology, 87(5), 539-547. doi:10.1212/wnl.0000000000002923Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., … Harvey, D. (2008). The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods. Journal of Magnetic Resonance Imaging, 27(4), 685-691. doi:10.1002/jmri.21049Kim, H., Caldairou, B., Bernasconi, A., & Bernasconi, N. (2018). Multi-Template Mesiotemporal Lobe Segmentation: Effects of Surface and Volume Feature Modeling. Frontiers in Neuroinformatics, 12. doi:10.3389/fninf.2018.00039Kivisaari, S. L., Probst, A., & Taylor, K. I. (2013). The Perirhinal, Entorhinal, and Parahippocampal Cortices and Hippocampus: An Overview of Functional Anatomy and Protocol for Their Segmentation in MR Images. fMRI, 239-267. doi:10.1007/978-3-642-34342-1_19Krumm, S., Kivisaari, S. L., Probst, A., Monsch, A. U., Reinhardt, J., Ulmer, S., … Taylor, K. I. (2016). Cortical thinning of parahippocampal subregions in very early Alzheimer’s disease. Neurobiology of Aging, 38, 188-196. doi:10.1016/j.neurobiolaging.2015.11.001Landau, S. M., Mintun, M. A., Joshi, A. D., Koeppe, R. A., Petersen, R. C., … Aisen, P. S. (2012). Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of Neurology, 72(4), 578-586. doi:10.1002/ana.23650Lehmann, M., Douiri, A., Kim, L. G., Modat, M., Chan, D., Ourselin, S., … Fox, N. C. (2010). Atrophy patterns in Alzheimer’s disease and semantic dementia: A comparison of FreeSurfer and manual volumetric measurements. NeuroImage, 49(3), 2264-2274. doi:10.1016/j.neuroimage.2009.10.056Leow, A. D., Klunder, A. D., Jack, C. R., Toga, A. W., Dale, A. M., Bernstein, M. A., … Thompson, P. M. (2006). Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. NeuroImage, 31(2), 627-640. doi:10.1016/j.neuroimage.2005.12.013Leung, K. K., Barnes, J., Ridgway, G. R., Bartlett, J. W., Clarkson, M. J., Macdonald, K., … Ourselin, S. (2010). Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer’s disease. NeuroImage, 51(4), 1345-1359. doi:10.1016/j.neuroimage.2010.03.018Mah, L., Binns, M. A., & Steffens, D. C. (2015). Anxiety Symptoms in Amnestic Mild Cognitive Impairment Are Associated with Medial Temporal Atrophy and Predict Conversion to Alzheimer Disease. The American Journal of Geriatric Psychiatry, 23(5), 466-476. doi:10.1016/j.jagp.2014.10.005Malykhin, N. V., Bouchard, T. P., Camicioli, R., & Coupland, N. J. (2008). Aging hippocampus and amygdala. NeuroReport, 19(5), 543-547. doi:10.1097/wnr.0b013e3282f8b18cMalykhin, N. V., Bouchard, T. P., Ogilvie, C. J., Coupland, N. J., Seres, P., & Camicioli, R. (2007). Three-dimensional volumetric analysis and reconstruction of amygdala and hippocampal head, body and tail. Psychiatry Research: Neuroimaging, 155(2), 155-165. doi:10.1016/j.pscychresns.2006.11.011Manjón, J. V., Coupé, P., Buades, A., Fonov, V., Louis Collins, D., & Robles, M. (2010). Non-local MRI upsampling. Medical Image Analysis, 14(6), 784-792. doi:10.1016/j.media.2010.05.010Martin, S. B., Smith, C. D., Collins, H. R., Schmitt, F. A., & Gold, B. T. (2010). Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment. Neurobiology of Aging, 31(7), 1099-1106. doi:10.1016/j.neurobiolaging.2008.08.010Mishra, S., Gordon, B. A., Su, Y., Christensen, J., Friedrichsen, K., Jackson, K., … Benzinger, T. L. S. (2017). AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure. NeuroImage, 161, 171-178. doi:10.1016/j.neuroimage.2017.07.050Mufson, E. J., & Pandya, D. N. (1984). Some observations on the course and composition of the cingulum bundle in the rhesus monkey. The Journal of Comparative Neurology, 225(1), 31-43. doi:10.1002/cne.902250105Olsen, R. K., Palombo, D. J., Rabin, J. S., Levine, B., Ryan, J. D., & Rosenbaum, R. S. (2013). Volumetric analysis of medial temporal lobe subregions in developmental amnesia using high‐resolution magnetic resonance imaging. Hippocampus, 23(10), 855-860. doi:10.1002/hipo.22153Olsen, R. K., Yeung, L.-K., Noly-Gandon, A., D’Angelo, M. C., Kacollja, A., Smith, V. M., … Barense, M. D. (2017). Human anterolateral entorhinal cortex volumes are associated with cognitive decline in aging prior to clinical diagnosis. Neurobiology of Aging, 57, 195-205. doi:10.1016/j.neurobiolaging.2017.04.025Palmqvist, S., Schöll, M., Strandberg, O., Mattsson, N., Stomrud, E., Zetterberg, H., … Hansson, O. (2017). Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nature Communications, 8(1). doi:10.1038/s41467-017-01150-xPasquini, L., Scherr, M., Tahmasian, M., Myers, N. E., Ortner, M., Kurz, A., … Sorg, C. (2016). Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer’s Disease Dementia. Journal of Alzheimer’s Disease, 51(1), 313-326. doi:10.3233/jad-150823Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183-194. doi:10.1111/j.1365-2796.2004.01388.xPetersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., … Jack, C. R. (2009). Mild Cognitive Impairment. Archives of Neurology, 66(12). doi:10.1001/archneurol.2009.266Preston, A. R., Bornstein, A. M., Hutchinson, J. B., Gaare, M. E., Glover, G. H., & Wagner, A. D. (2010). High-resolution fMRI of Content-sensitive Subsequent Memory Responses in Human Medial Temporal Lobe. Journal of Cognitive Neuroscience, 22(1), 156-173. doi:10.1162/jocn.2009.21195Qiu, A., Fennema-Notestine, C., Dale, A. M., & Miller, M. I. (2009). Regional shape abnormalities in mild cognitive impairment and Alzheimer’s disease. NeuroImage, 45(3), 656-661. doi:10.1016/j.neuroimage.2009.01.013Wisse, L. E. M., Gerritsen, L., Zwanenburg, J. J. M., Kuijf, H. J., Luijten, P. R., Biessels, G. J., & Geerlings, M. I. (2012). Subfields of the hippocampal formation at 7T MRI: In vivo volumetric assessment. NeuroImage, 61(4), 1043-1049. doi:10.1016/j.neuroimage.2012.03.023Wisse, L. E. M., Biessels, G. J., & Geerlings, M. I. (2014). A Critical Appraisal of the Hippocampal Subfield Segmentation Package in FreeSurfer. Frontiers in Aging Neuroscience, 6. doi:10.3389/fnagi.2014.00261Witter, M., Van Hoesen, G., & Amaral, D. (1989). Topographical organization of the entorhinal projection to the dentate gyrus of the monkey. The Journal of Neuroscience, 9(1), 216-228. doi:10.1523/jneurosci.09-01-00216.1989Wolk, D. A., & Dickerson, B. C. (2011). Fractionating verbal episodic memory in Alzheimer’s disease. NeuroImage, 54(2), 1530-1539. doi:10.1016/j.neuroimage.2010.09.005Xie, L., Shinohara, R. T., Ittyerah, R., Kuijf, H. J., Pluta, J. B., Blom, K., … Wisse, L. E. M. (2018). Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer’s Disease at 3T and 7T: What Atlas Composition Works Best? Journal of Alzheimer’s Disease, 63(1), 217-225. doi:10.3233/jad-170932Yushkevich, P. A., Piven, J., Hazlett, H. C., Smith, R. G., Ho, S., Gee, J. C., & Gerig, G. (2006). User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. NeuroImage, 31(3), 1116-1128. doi:10.1016/j.neuroimage.2006.01.015Zeineh, M. M., Engel, S. A., Thompson, P. M., & Bookheimer, S. Y. (2001). Unfolding the human hippocampus with high resolution structural and functional MRI. The Anatomical Record, 265(2), 111-120. doi:10.1002/ar.106

Prevention and early detection of prostate cancer

This Review was sponsored and funded by the International Society of Cancer Prevention (ISCaP), the European Association of Urology (EAU), the National Cancer Institute, USA (NCI) (grant number 1R13CA171707-01), Prostate Cancer UK, Cancer Research UK (CRUK) (grant number C569/A16477), and the Association for International Cancer Research (AICR

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease

Biomarkers of brain Aβ amyloid deposition can be measured either by cerebrospinal fluid Aβ42 or Pittsburgh compound B positron emission tomography imaging. Our objective was to evaluate the ability of Aβ load and neurodegenerative atrophy on magnetic resonance imaging to predict shorter time-to-progression from mild cognitive impairment to Alzheimer’s dementia and to characterize the effect of these biomarkers on the risk of progression as they become increasingly abnormal. A total of 218 subjects with mild cognitive impairment were identified from the Alzheimer’s Disease Neuroimaging Initiative. The primary outcome was time-to-progression to Alzheimer’s dementia. Hippocampal volumes were measured and adjusted for intracranial volume. We used a new method of pooling cerebrospinal fluid Aβ42 and Pittsburgh compound B positron emission tomography measures to produce equivalent measures of brain Aβ load from either source and analysed the results using multiple imputation methods. We performed our analyses in two phases. First, we grouped our subjects into those who were ‘amyloid positive’ (n = 165, with the assumption that Alzheimer's pathology is dominant in this group) and those who were ‘amyloid negative’ (n = 53). In the second phase, we included all 218 subjects with mild cognitive impairment to evaluate the biomarkers in a sample that we assumed to contain a full spectrum of expected pathologies. In a Kaplan–Meier analysis, amyloid positive subjects with mild cognitive impairment were much more likely to progress to dementia within 2 years than amyloid negative subjects with mild cognitive impairment (50 versus 19%). Among amyloid positive subjects with mild cognitive impairment only, hippocampal atrophy predicted shorter time-to-progression (P < 0.001) while Aβ load did not (P = 0.44). In contrast, when all 218 subjects with mild cognitive impairment were combined (amyloid positive and negative), hippocampal atrophy and Aβ load predicted shorter time-to-progression with comparable power (hazard ratio for an inter-quartile difference of 2.6 for both); however, the risk profile was linear throughout the range of hippocampal atrophy values but reached a ceiling at higher values of brain Aβ load. Our results are consistent with a model of Alzheimer’s disease in which Aβ deposition initiates the pathological cascade but is not the direct cause of cognitive impairment as evidenced by the fact that Aβ load severity is decoupled from risk of progression at high levels. In contrast, hippocampal atrophy indicates how far along the neurodegenerative path one is, and hence how close to progressing to dementia. Possible explanations for our finding that many subjects with mild cognitive impairment have intermediate levels of Aβ load include: (i) individual subjects may reach an Aβ load plateau at varying absolute levels; (ii) some subjects may be more biologically susceptible to Aβ than others; and (iii) subjects with mild cognitive impairment with intermediate levels of Aβ may represent individuals with Alzheimer’s disease co-existent with other pathologies

Evidence against GB virus C infection in dromedary camels

A recent publication described finding GB virus C (GBV-C) RNA in four of twenty two dromedary camel sera, and sequence analysis found that these viruses were phylogenetically clustered within human GBV-C isolates. Since all other GB viruses to date form monophyletic groups according to their host species, the close relationship between the sequences generated from camel sera and human GBV-C isolates seemed implausible, leading us to conduct an independent analysis of the sequences. Our investigation found three lines of evidence arguing against GBV-C infection in dromedary camels. First, strong evidence of artifactual sequence generation was identified for some of the sequences. Secondly, the sequence diversity within individual camel sera was ten- to one-hundred fifty two-fold greater than that described for GBV-C within a human host. Finally, GBV-C sequences generated from each camel shared near complete identity with human isolates previously described by the same laboratory. Taken together, these data strongly suggest laboratory contamination. We suggest that additional validation experiments are needed before it is possible to conclude that camels are permissive for GBV-C infection

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

Alzheimer’s disease (AD) is defined by amyloid (A) and tau (T) pathologies, with T better correlated to neurodegeneration (N). However, T and N have complex regional relationships in part related to non-AD factors that influence N. With machine learning, we assessed heterogeneity in 18F-flortaucipir vs. 18F-fluorodeoxyglucose positron emission tomography as markers of T and neuronal hypometabolism (NM) in 289 symptomatic patients from the Alzheimer’s Disease Neuroimaging Initiative. We identified six T/NM clusters with differing limbic and cortical patterns. The canonical group was defined as the T/NM pattern with lowest regression residuals. Groups resilient to T had less hypometabolism than expected relative to T and displayed better cognition than the canonical group. Groups susceptible to T had more hypometabolism than expected given T and exhibited worse cognitive decline, with imaging and clinical measures concordant with non-AD copathologies. Together, T/NM mismatch reveals distinct imaging signatures with pathobiological and prognostic implications for AD

Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications

In the past decade, positron emission tomography (PET) with carbon-11-labeled Pittsburgh Compound B (PIB) has revolutionized the neuroimaging of aging and dementia by enabling in vivo detection of amyloid plaques, a core pathologic feature of Alzheimer's disease (AD). Studies suggest that PIB-PET is sensitive for AD pathology, can distinguish AD from non-AD dementia (for example, frontotemporal lobar degeneration), and can help determine whether mild cognitive impairment is due to AD. Although the short half-life of the carbon-11 radiolabel has thus far limited the use of PIB to research, a second generation of tracers labeled with fluorine-18 has made it possible for amyloid PET to enter the clinical era. In the present review, we summarize the literature on amyloid imaging in a range of neurodegenerative conditions. We focus on potential clinical applications of amyloid PET and its role in the differential diagnosis of dementia. We suggest that amyloid imaging will be particularly useful in the evaluation of mildly affected, clinically atypical or early age-at-onset patients, and illustrate this with case vignettes from our practice. We emphasize that amyloid imaging should supplement (not replace) a detailed clinical evaluation. We caution against screening asymptomatic individuals, and discuss the limited positive predictive value in older populations. Finally, we review limitations and unresolved questions related to this exciting new technique

P1‐349: Advancing Clinical And Biomarker Research In Ad: The Lead Study

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152716/1/alzjjalz201906904.pd

International pooled study on diet and bladder cancer: The bladder cancer, epidemiology and nutritional determinants (BLEND) study: Design and baseline characteristics

In 2012, more than 400,000 urinary bladder cancer cases occurred worldwide, making it the 7th most common type of cancer. Although many previous studies focused on the relationship between diet and bladder cancer, the evidence related to specific food items or nutrients that could be involved in the development of bladder cancer remains inconclusive. Dietary components can either be, or be activated into, potential carcinogens through metabolism, or act to prevent carcinogen damage